Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners considers the findings of a study into the increasing importance of standard essential patents and their licensing in Japan -
Sponsored by Bugnion SpAMarco Lissandrini of Bugnion likens the decision in G1/19 to a round of golf, explaining the three-step pattern of reasoning to assess inventiveness
-
Sponsored by Gün and PartnersUğur Aktekin and Begüm Soydan of Gün and Partners explain why the Court of Cassation’s decision has evoked a mixed reaction from trademark filers
-
Sponsored by OLIVARESDiego Ballesteros of OLIVARES examines the evolving law of declaring trademarks in Mexico
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners takes a closer look at how the Japanese government’s approach to the strategic acquisition and utilisation of SEPs will change
-
Sponsored by Vivien Chan & CoExperts from Vivien Chan & Co report on significant developments from the IP world across China and the Asia-Pacific
